BCRX Q3'26 Earnings Preview
BioCryst Pharmaceuticals is scheduled to report Q3'26 results on November 4 before the market opens. Revenue and EPS estimates are provided in the source.
Related stories
RDACU: trading halted on Nasdaq — volatility pause (9:30 AM ET)
Nasdaq halted trading in RDACU (volatility pause) at 9:30 AM ET.
L impact | EQUITY | Nov 03, 2026, 02:40 PM UTC
Bank Of America Shares Hit 30-week Low
Bank Of America shares decreased to 49.22 USD, the lowest since April 2026. Over the past 4 weeks, Bank Of America lost 8.44%, and in the last 12 months, it decreased 7.69%.
L impact | EQUITY | Nov 03, 2026, 02:31 PM UTC
Dow Jones falls 206.75 points to 51,777.23 after open
M impact | EQUITY | Nov 03, 2026, 02:31 PM UTC
S&P 500 Rises 7.77 Points to 7,549.17 After Open
The S&P 500 was up 7.77 points at 7,549.17 after the market opened.
M impact | EQUITY | Nov 03, 2026, 02:31 PM UTC
Nasdaq rises 98.65 points, or 0.39 percent, to 25,263.01 after open
M impact | EQUITY | Nov 03, 2026, 02:31 PM UTC
Opera Reports Q3 Revenue Growth of 20%
Opera reported Q3 revenue growth of 20%.
M impact | EQUITY | Nov 03, 2026, 02:31 PM UTC